Regeneca News
Press Release
For more information on Regeneca including the company's current rank in our home business index, please Click here.
Regeneca Given Distribution Rights for CardioMap
Cottonwood Heights, UT June 11, 2015 -- Regeneca Worldwide has entered into an exclusive distribution agreement with VE Science Technologies LLC, the creators of the CardioMap heart screening and monitor device, for the network marketing industry. “We are very excited about this deal, as the distribution with Regeneca Worldwide offers an incredible opportunity for the advancement of this technology in terms of awareness and applicability in the daily lives of individuals,” stated Vladimir Podlipskiy, the Chief Science Officer of VE Science Technologies LLC. “CardioMap provides the basis for an analysis of a person’s heart health condition. This analysis is achieved through an examination that measures heart performance and visualizes the results in dynamic, colorful heart portraits generated through an online service. This invaluable service addresses unmet needs in early screening and monitoring for heart disease, and other health related conditions.” “CardioMap provides a way for our distributors to instantly demonstrate the effectiveness of the Regeneca product line, with individualized data for our consumers,” said Trent Staggs, President of Regeneca Worldwide, Inc. CardioMap depicts disease or stress levels as a 3D image supplementing the line drawing electrocardiogram. The system evaluates the stability of current heart conditions. It is highly portable and provides a rapid analysis in 30 or 60 seconds. The device is connected through the Internet to the central server that converts the electric conductivity of the cardiac tissue into a three-dimensional, color-coded and easy-to-interpret visual portrait. This heart portrait allows customers and physicians to observe the condition of the heart muscle and the intensity of the heart stress load quickly and easily.